1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39:119-77.
2. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation.2013;127:529-55.
3. Amier RP, Tijssen RYG, Teunissen PFA, Fernández-Jiménez R, Pizarro G, García-Lunar I, et al. Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc.2017; 6:e005651.
4. Symons R, Pontone G, Schwitter J, Francone M, Iglesias JF, Barison A, et al. Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI. JACC Cardiovasc Imaging. 2018; 11:813-25.
5. Betgem RP, de Waard GA, Nijveldt R, Beek AM, Escaned J, van Royen N.
Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol. 2015;12:156-67.
6. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR,
Horrevoets AJ, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013; 34:2346-53.
7. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011;4:354–62.
8.Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, et al. Impact of myocardial haemorrhage on left ventricular function and
remodelling in patients with reperfused acute myocardial infarction. Eur Heart J.
2009; 30:1440-9.
9.Beek AM, Nijveldt R, van Rossum AC. Intramyocardial hemorrhage and
microvascular obstruction after primary percutaneous intervention. Int J
Cardiovasc Imaging. 2010; 26:49-55.
10.Reinstadler SJ, StiermaierT, ReindlM, FeistritzerHJ, Fuernau G, Eitel C,
et al. Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2019;20(2):138-46.
11. Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, et al. Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance. Circ Cardiovasc Imaging. 2016;9:e004148.
12. Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC
Cardiovasc Imaging. 2014;7:940–52.
13. Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, et al. Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019; 16;74:238-56.
14. Niccoli G, Scalone G, Lerman A, Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016; 37(13):1024-33.
15. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP. The innate immune response in reperfused myocardium.Cardiovasc Res. 2012; 94:
276-83.
16. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular
obstruction-related myocardial injury and coronary no-reflow following percutaneous
coronary intervention: a systematic approach. JACC Cardiovasc Interv.2010; 3:695
-704.
17. Mahajan D, Wang Y, Qin X, Wang Y, Zheng G, Wang YM, et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol.2006;17:2731-41.
18. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, et al. Regulatory T Cells Suppress Innate Immunity in Kidney Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2009;20:1744-53.
19. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive Regulatory T-Cell Therapy Protects Against Cerebral Ischemia. Ann Neurol. 2013; 74:458-71.
20. Xia N, Jiao N, Tang TT, Lv BJ, Lu YZ, Wang KJ, et al. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism. Clin Sci. 2015;128:679-93.
21. Xiao J, Yu K, Li M, Xiong C, Wei Y, Zeng Q. The IL-2/Anti-IL-2 Complex Attenuates Cardiac Ischaemia-Reperfusion Injury Through Expansion of Regulatory T Cells. Cell Physiol Biochem. 2017;44:1810-27.
22. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006; 212:8-27.
23.Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018; 137(12): e67-e492.
24. Lotan CS, Bouchard A, Cranney GB, Bishop SP, Pohost GM. Assessment
of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T.
Circulation. 1992;86(3):1018-25.
25. Husser O, Monmeneu JV, Sanchis J, Nunez J, Lopez-Lereu MP, Bonanad C,
et al. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. International Journal of Cardiology.
2013; 2047-54
26. Zhang X, Du Q, Yang Y, Wang J, Dou S, Liu C, et al. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/
NLRP3 inflammasome pathway. Biomed Pharmacother. 2017;91:1042-52.